Apolipoprotein E interrupts interleukin-1beta signaling in vascular smooth muscle cells. 2007

Akira Kawamura, and Daniel Baitsch, and Ralph Telgmann, and Renata Feuerborn, and Gabriele Weissen-Plenz, and Claudia Hagedorn, and Keijiro Saku, and Stefan-Martin Brand-Herrmann, and Arnold von Eckardstein, and Gerd Assmann, and Jerzy-Roch Nofer
Department of Lipid Metabolism, Leibniz-Institut für Arterioskleroseforschung an der Universität Münster, Germany.

OBJECTIVE Apolipoprotein E (apoE) exerts antiatherogenic effects but precise mechanisms remain unclear. We here investigated the effect of apoE on intracellular signaling by interleukin-1beta (IL-1beta), a proinflammatory cytokine present in atherosclerotic lesions. RESULTS IL-1beta-induced expression and activation of inducible nitric oxide synthase and cyclooxygenase-2 were inhibited by apoE in vascular smooth muscle cells (VSMCs). These inhibitory effects were linked to the suppression of both NF-kappaB and activating protein-1 (AP-1) transactivation, suggesting that the interruption of IL-1beta signaling occurs upstream of transcription factors. Studies in VSMCs overexpressing IL-1beta signaling intermediates revealed that NF-kappaB transactivation was inhibited by apoE in MyD88- and IRAK1- but not in TRAF6-transfected cells. Furthermore, apoE prevented IRAK1 phosphorylation and IRAK1-TRAF6 but not MyD88-IRAK1 complex formation. Inhibitory effects of apoE on IL-1beta signaling were abolished after silencing LDL receptor-related protein-1 (LRP1) expression with siRNA. In addition, inhibitors of adenylyl cyclase and protein kinase A (PKA) restored IL-1beta signaling in apoE-treated VSMCs, whereas apoE stimulated PKA activity. ApoE inhibited VSMC activation in response to IL-18 but not to tumor necrosis factor-alpha or polyinosinic:polycytidylic acid. CONCLUSIONS ApoE targets IRAK-1 activation and thereby interrupts IL-1beta and IL-18 signaling in VSMCs. This antiinflammatory effect represents a novel antiatherogenic activity of apoE.

UI MeSH Term Description Entries
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D050197 Atherosclerosis A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA. Atherogenesis,Atherogeneses,Atheroscleroses
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D051546 Cyclooxygenase 2 An inducibly-expressed subtype of prostaglandin-endoperoxide synthase. It plays an important role in many cellular processes and INFLAMMATION. It is the target of COX2 INHIBITORS. COX-2 Prostaglandin Synthase,Cyclo-Oxygenase II,Cyclooxygenase-2,PGHS-2,PTGS2,Prostaglandin H Synthase-2,COX 2 Prostaglandin Synthase,Cyclo Oxygenase II,Prostaglandin H Synthase 2,Prostaglandin Synthase, COX-2,Synthase, COX-2 Prostaglandin

Related Publications

Akira Kawamura, and Daniel Baitsch, and Ralph Telgmann, and Renata Feuerborn, and Gabriele Weissen-Plenz, and Claudia Hagedorn, and Keijiro Saku, and Stefan-Martin Brand-Herrmann, and Arnold von Eckardstein, and Gerd Assmann, and Jerzy-Roch Nofer
April 1997, The Journal of experimental medicine,
Akira Kawamura, and Daniel Baitsch, and Ralph Telgmann, and Renata Feuerborn, and Gabriele Weissen-Plenz, and Claudia Hagedorn, and Keijiro Saku, and Stefan-Martin Brand-Herrmann, and Arnold von Eckardstein, and Gerd Assmann, and Jerzy-Roch Nofer
April 2020, International journal of molecular sciences,
Akira Kawamura, and Daniel Baitsch, and Ralph Telgmann, and Renata Feuerborn, and Gabriele Weissen-Plenz, and Claudia Hagedorn, and Keijiro Saku, and Stefan-Martin Brand-Herrmann, and Arnold von Eckardstein, and Gerd Assmann, and Jerzy-Roch Nofer
February 1996, European journal of pharmacology,
Akira Kawamura, and Daniel Baitsch, and Ralph Telgmann, and Renata Feuerborn, and Gabriele Weissen-Plenz, and Claudia Hagedorn, and Keijiro Saku, and Stefan-Martin Brand-Herrmann, and Arnold von Eckardstein, and Gerd Assmann, and Jerzy-Roch Nofer
January 2004, Journal of biomedical science,
Akira Kawamura, and Daniel Baitsch, and Ralph Telgmann, and Renata Feuerborn, and Gabriele Weissen-Plenz, and Claudia Hagedorn, and Keijiro Saku, and Stefan-Martin Brand-Herrmann, and Arnold von Eckardstein, and Gerd Assmann, and Jerzy-Roch Nofer
August 1998, The Journal of biological chemistry,
Akira Kawamura, and Daniel Baitsch, and Ralph Telgmann, and Renata Feuerborn, and Gabriele Weissen-Plenz, and Claudia Hagedorn, and Keijiro Saku, and Stefan-Martin Brand-Herrmann, and Arnold von Eckardstein, and Gerd Assmann, and Jerzy-Roch Nofer
January 1999, Hypertension (Dallas, Tex. : 1979),
Akira Kawamura, and Daniel Baitsch, and Ralph Telgmann, and Renata Feuerborn, and Gabriele Weissen-Plenz, and Claudia Hagedorn, and Keijiro Saku, and Stefan-Martin Brand-Herrmann, and Arnold von Eckardstein, and Gerd Assmann, and Jerzy-Roch Nofer
March 2005, Free radical biology & medicine,
Akira Kawamura, and Daniel Baitsch, and Ralph Telgmann, and Renata Feuerborn, and Gabriele Weissen-Plenz, and Claudia Hagedorn, and Keijiro Saku, and Stefan-Martin Brand-Herrmann, and Arnold von Eckardstein, and Gerd Assmann, and Jerzy-Roch Nofer
December 2007, Reproduction (Cambridge, England),
Akira Kawamura, and Daniel Baitsch, and Ralph Telgmann, and Renata Feuerborn, and Gabriele Weissen-Plenz, and Claudia Hagedorn, and Keijiro Saku, and Stefan-Martin Brand-Herrmann, and Arnold von Eckardstein, and Gerd Assmann, and Jerzy-Roch Nofer
January 1999, Circulation research,
Akira Kawamura, and Daniel Baitsch, and Ralph Telgmann, and Renata Feuerborn, and Gabriele Weissen-Plenz, and Claudia Hagedorn, and Keijiro Saku, and Stefan-Martin Brand-Herrmann, and Arnold von Eckardstein, and Gerd Assmann, and Jerzy-Roch Nofer
January 2017, Advances in pharmacology (San Diego, Calif.),
Copied contents to your clipboard!